In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1

Summary We examined serum IGF-1 in premenopausal IOP, finding relationships that were opposite to those expected: higher IGF-1 was associated with lower bone formation and higher body fat, and lower BMD response to teriparatide. These paradoxical relationships between serum IGF-1, bone, and fat may...

Full description

Saved in:

Bibliographic Details
Published in:	Osteoporosis international Vol. 33; no. 3; pp. 659 - 672
Main Authors:	Goetz, T.G., Nair, N., Shiau, S., Recker, R.R., Lappe, J.M., Dempster, D.W., Zhou, H., Zhao, B., Guo, X., Shen, W., Nickolas, T.L., Kamanda-Kosseh, M., Bucovsky, M., Stubby, J., Shane, E., Cohen, A.
Format:	Journal Article
Language:	English
Published:	London Springer London 01-03-2022 Springer Nature B.V
Subjects:	Adipose Tissue Biopsy Body fat Bone Density Bone Density Conservation Agents - therapeutic use Bone growth Bone remodeling Cancellous bone Cardiovascular diseases Dual energy X-ray absorptiometry Endocrinology Female Humans Insulin-Like Growth Factor I Leptin Magnetic resonance imaging Medicine Medicine & Public Health Original Article Orthopedics Osteogenesis Osteoporosis Osteoporosis - drug therapy Osteoporosis - etiology Parathyroid hormone Rheumatology Teriparatide - therapeutic use Bone biopsy Marrow adiposity Premenopausal osteoporosis Bone turnover markers Body composition Teriparatide
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Summary We examined serum IGF-1 in premenopausal IOP, finding relationships that were opposite to those expected: higher IGF-1 was associated with lower bone formation and higher body fat, and lower BMD response to teriparatide. These paradoxical relationships between serum IGF-1, bone, and fat may contribute to the mechanism of idiopathic osteoporosis in premenopausal women. Introduction Premenopausal women with idiopathic osteoporosis (IOP) have marked deficits in bone microarchitecture but variable bone remodeling. We previously reported that those with low tissue-level bone formation rate (BFR) are less responsive to teriparatide and have higher serum IGF-1, a hormone anabolic for osteoblasts and other tissues. The IGF-1 data were unexpected because IGF-1 is low in other forms of low turnover osteoporosis—leading us to hypothesize that IGF-1 relationships are paradoxical in IOP. This study aimed to determine whether IOP women with low BFR have higher IGF-1 and paradoxical IGF-1 relationships in skeletal and non-skeletal tissues, and whether IGF-1 and the related measures predict teriparatide response. Methods This research is an ancillary study to a 24 month clinical trial of teriparatide for IOP. Baseline assessments were related to trial outcomes: BMD, bone remodeling. Subjects: Premenopausal women with IOP( n = 34); bone remodeling status was defined by baseline cancellous BFR/BS on bone biopsy. Measures: Serum IGF-1 parameters, compartmental adiposity (DXA, CT, MRI), serum hormones, and cardiovascular-risk-markers related to fat distribution. Results As seen in other populations, lower BFR was associated with higher body fat and poorer teriparatide response. However, in contrast to observations in other populations, low BFR, higher body fat, and poorer teriparatide response were all related to higher IGF-1: IGF-1 Z-score was inversely related to BFR at all bone surfaces ( r = − 0.39 to − 0.46; p < 0.05), directly related to central fat ( p = 0.05) and leptin ( p = 0.03). IGF-1 inversely related to 24 month hip BMD %change ( r = − 0.46; p = 0.01). Conclusions Paradoxical IGF-1 relationships suggest that abnormal or atypical regulation of bone and fat may contribute to osteoporosis mechanisms in premenopausal IOP.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0937-941X 1433-2965
DOI:	10.1007/s00198-021-06196-8